Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer

[1]  R. Blamey,et al.  A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up. , 2011, Critical reviews in oncology/hematology.

[2]  I. Ellis,et al.  Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre , 2011, British Journal of Cancer.

[3]  J. Cuzick,et al.  Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  L. Jackson,et al.  Neoadjuvant endocrine treatment in primary breast cancer - review of literature. , 2009, Breast.

[5]  Jun Suk Kim,et al.  Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer , 2008, Cancer Chemotherapy and Pharmacology.

[6]  A. Howell,et al.  Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 years , 2007, British Journal of Cancer.

[7]  M. Reed,et al.  Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review , 2007, British Journal of Cancer.

[8]  J. Coebergh,et al.  Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. , 2005, European journal of cancer.

[9]  G. Hortobagyi,et al.  Breast cancer treatment guidelines in older women. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Baum,et al.  Late follow‐up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer , 2004, The British journal of surgery.

[11]  M. Reed,et al.  Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines , 2004, British Journal of Cancer.

[12]  G. Vlastos,et al.  Undertreatment strongly decreases prognosis of breast cancer in elderly women. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  V. Velanovich,et al.  Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. , 2002, Journal of the American College of Surgeons.

[14]  E. McDermott,et al.  Tamoxifen as the primary treatment in elderly patients with breast cancer , 2002, Irish journal of medical science.

[15]  M. Ellis,et al.  Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  R. Elledge,et al.  Tumor characteristics and clinical outcome of elderly women with breast cancer. , 2000, Journal of the National Cancer Institute.

[17]  I. Ellis,et al.  Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer , 1997 .

[18]  L. Jackson,et al.  Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer , 1997 .

[19]  W. Satariano,et al.  The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer , 1994, Annals of Internal Medicine.

[20]  A. Hart,et al.  The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study. , 1992, European journal of cancer.

[21]  L. Fallowfield,et al.  Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone , 1991, The British journal of surgery.

[22]  I. Ellis,et al.  Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. , 1988, BMJ.

[23]  S. Wells,et al.  Relationship of Age and Menopausal Status to Estrogen Receptor Content in Primary Carcinoma of the Breast , 1983, Annals of surgery.